Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.926,88
-0,23%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Biora Therapeutics Inc (PROG) Biora Therapeutics Inc (PROG) Notizie

PROG

Biora Therapeutics (PROG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PROG
DataOraFonteTitoloSimboloCompagnia
16/06/202322:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PROGBiora Therapeutics Inc
15/06/202322:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PROGBiora Therapeutics Inc
13/06/202316:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PROGBiora Therapeutics Inc
13/06/202316:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PROGBiora Therapeutics Inc
27/04/202322:41Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PROGBiora Therapeutics Inc
27/04/202322:34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PROGBiora Therapeutics Inc
13/03/202321:19Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PROGBiora Therapeutics Inc
27/01/202323:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PROGBiora Therapeutics Inc
09/12/202223:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PROGBiora Therapeutics Inc
10/11/202223:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PROGBiora Therapeutics Inc
10/05/202222:44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PROGBiora Therapeutics Inc
05/05/202212:30GlobeNewswire Inc.Progenity Announces Successful Transfer of Liquid Biopsy TechnologiesNASDAQ:PROGBiora Therapeutics Inc
03/05/202215:00GlobeNewswire Inc.Progenity to Report First Quarter Financial Results and Provide Corporate Update as Biora Therapeutics, Inc.NASDAQ:PROGBiora Therapeutics Inc
25/04/202215:00GlobeNewswire Inc.Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s Ingestible Drug/Device PlatformsNASDAQ:PROGBiora Therapeutics Inc
12/04/202215:00GlobeNewswire Inc.Progenity to Become Biora Therapeutics as it Completes TransformationNASDAQ:PROGBiora Therapeutics Inc
06/04/202215:00GlobeNewswire Inc.Progenity Announces Two Poster Presentations at Controlled Release Society 2022NASDAQ:PROGBiora Therapeutics Inc
30/03/202204:27TipRanksRobert W. Baird Keeps a Hold Rating on Progenity (PROG)NASDAQ:PROGBiora Therapeutics Inc
29/03/202214:25TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Progenity (PROG)NASDAQ:PROGBiora Therapeutics Inc
28/03/202223:18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PROGBiora Therapeutics Inc
28/03/202222:39Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PROGBiora Therapeutics Inc
28/03/202222:01GlobeNewswire Inc.Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:PROGBiora Therapeutics Inc
16/03/202221:23GlobeNewswire Inc.Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate UpdateNASDAQ:PROGBiora Therapeutics Inc
10/03/202217:45TipRanksH.C. Wainwright Thinks Progenity’s Stock is Going to RecoverNASDAQ:PROGBiora Therapeutics Inc
10/03/202215:00GlobeNewswire Inc.Progenity Progresses its Drug Delivery System Clinical Device Performance StudiesNASDAQ:PROGBiora Therapeutics Inc
28/02/202215:00GlobeNewswire Inc.Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022NASDAQ:PROGBiora Therapeutics Inc
22/02/202215:00GlobeNewswire Inc.Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO’22NASDAQ:PROGBiora Therapeutics Inc
16/02/202215:00GlobeNewswire Inc.Progenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of GastroenterologyNASDAQ:PROGBiora Therapeutics Inc
25/01/202222:05GlobeNewswire Inc.Progenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional PatentNASDAQ:PROGBiora Therapeutics Inc
23/01/202209:34TipRanksProgenity: Risks, Red Flags, and Poor FundamentalsNASDAQ:PROGBiora Therapeutics Inc
11/01/202212:30GlobeNewswire Inc.Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of GastroenterologyNASDAQ:PROGBiora Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PROG

La tua Cronologia

NASDAQ
HURN
Huron Consulting
EU
M849S
M849S
EU
HOMI
Home Invest Belgium NV
KOSPI
267260
HD Hyundai Electric
BIT
LUVE
LU-VE S.p.A
BIT
P14P92
BNP Paribas Issuance
BIT
UC8T3L
Unicredit Bank
COIN
UCASHGBP
COIN
BUNNYYYUSD
Rocket Bunny
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network